JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$438M |
| 3 |
Royal Caribbean
RCL
|
+$434M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$432M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$424M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.08B |
| 2 |
Meta Platforms (Facebook)
META
|
+$722M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$721M |
| 4 |
Apple
AAPL
|
+$701M |
| 5 |
Netflix
NFLX
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.51% |
| 2 | Financials | 13.49% |
| 3 | Technology | 11.69% |
| 4 | Healthcare | 10.22% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SYUT
4126
DELISTED
Synutra International, Inc.
SYUT
| $7K | ﹤0.01% |
1,417
+280
| +25% | +$1.36K |
2015 Q4
1 quarter
|
|
|
TXTR
4127
DELISTED
TEXTURA CORPORATION COM
TXTR
| $7K | ﹤0.01% |
+399
| New | +$6.71K |
2016 Q1
0 quarters
|
|
|
HSKA
4128
DELISTED
Heska Corp
HSKA
| $7K | ﹤0.01% |
+252
| New | +$8.35K |
2016 Q1
0 quarters
|
|
|
SPHS
4129
DELISTED
Sophiris Bio, Inc.
SPHS
| $7K | ﹤0.01% |
+4,200
| New | +$7.41K |
2016 Q1
0 quarters
|
|
|
TIVO
4130
DELISTED
TIVO INC
TIVO
| $7K | ﹤0.01% |
735
+695
| +1,738% | +$5.59K |
2015 Q4
1 quarter
|
|
|
GCVRZ
4131
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $7K | ﹤0.01% |
62,381
-34,170
| -35% | -$3.7K |
2015 Q1
4 quarters
|
|
4132
1-800-Flowers.com
FLWS
$162M
| $6K | ﹤0.01% |
809
-649
| -45% | -$4.86K |
2015 Q4
1 quarter
|
|
4133
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.67B
| $6K | ﹤0.01% |
302
| – | – |
2015 Q4
1 quarter
|
|
4134
Iovance Biotherapeutics
IOVA
$6.5B
| $6K | ﹤0.01% |
1,149
+774
| +206% | +$4.24K |
2015 Q4
1 quarter
|
|
4135
Lineage Cell Therapeutics
LCTX
$239M
| $6K | ﹤0.01% |
2,270
-1,219
| -35% | -$2.72K |
2015 Q4
1 quarter
|
|
4136
Mine Safety
MSA
$7.11B
| $6K | ﹤0.01% |
127
+40
| +46% | +$1.73K |
2015 Q4
1 quarter
|
|
4137
National CineMedia
NCMI
$199M
| $6K | ﹤0.01% |
39
+9
| +30% | +$1.35K |
2015 Q4
1 quarter
|
|
|
NVMI
4138
Nova
NVMI
$12.6B
| $6K | ﹤0.01% |
+619
| New | +$6.16K |
2016 Q1
0 quarters
|
|
4139
Phibro Animal Health
PAHC
$1.51B
| $6K | ﹤0.01% |
216
+174
| +414% | +$4.99K |
2014 Q2
7 quarters
|
|
4140
Saia
SAIA
$9.3B
| $6K | ﹤0.01% |
222
| – | – |
2015 Q4
1 quarter
|
|
|
SGMO
4141
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $6K | ﹤0.01% |
854
+771
| +929% | +$4.63K |
2015 Q4
1 quarter
|
|
4142
Willdan Group
WLDN
$1.12B
| $6K | ﹤0.01% |
+600
| New | +$4.99K |
2016 Q1
0 quarters
|
|
|
ONIT
4143
Onity Group
ONIT
$229M
| $6K | ﹤0.01% |
170
-106
| -38% | -$7.28K |
2013 Q2
11 quarters
|
|
|
LGTY
4144
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $6K | ﹤0.01% |
705
| – | – |
2015 Q4
1 quarter
|
|
|
AGRX
4145
DELISTED
Agile Therapeutics
AGRX
| – | – |
0
| – | – |
2015 Q4
1 quarter
|
|
|
VCRA
4146
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $6K | ﹤0.01% |
465
-59
| -11% | -$817 |
2015 Q4
1 quarter
|
|
|
ECHO
4147
DELISTED
Echo Global Logistics, Inc.
ECHO
| $6K | ﹤0.01% |
184
+165
| +868% | +$3.93K |
2015 Q4
1 quarter
|
|
|
FPRX
4148
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $6K | ﹤0.01% |
154
| – | – |
2015 Q4
1 quarter
|
|
|
BITA
4149
DELISTED
Bitauto Holdings Limited
BITA
| $6K | ﹤0.01% |
235
-39
| -14% | -$858 |
2014 Q2
7 quarters
|
|
|
BEL
4150
DELISTED
Belmond Ltd.
BEL
| $6K | ﹤0.01% |
634
+372
| +142% | +$3.31K |
2014 Q4
5 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2016 Portfolio in Review
As of Q1 2016, JP Morgan Chase held 5,307 positions worth $391B, down 1.9% from $398B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2016 filing shows 536 new, 1,742 increased, 1,913 reduced and 585 closed positions. Its largest new stake was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $1.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 20% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2016 buy was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2016, an estimated $2.23B increase.
- JP Morgan Chase's biggest Q1 2016 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $1.08B.
- JP Morgan Chase fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $721M.
- JP Morgan Chase's ten largest holdings make up 17% of its $391B portfolio in Q1 2016.
- JP Morgan Chase opened 536 new positions and closed 585 in Q1 2016.
- JP Morgan Chase's portfolio value fell 1.9% quarter-over-quarter to $391B.
Based on JP Morgan Chase's 13F filing for Q1 2016, filed 10 May 2016.